Sarah E. Mayson

809 total citations
14 papers, 233 citations indexed

About

Sarah E. Mayson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sarah E. Mayson has authored 14 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sarah E. Mayson's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Thyroid and Parathyroid Surgery (4 papers) and Pituitary Gland Disorders and Treatments (3 papers). Sarah E. Mayson is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Thyroid and Parathyroid Surgery (4 papers) and Pituitary Gland Disorders and Treatments (3 papers). Sarah E. Mayson collaborates with scholars based in United States, Italy and Singapore. Sarah E. Mayson's co-authors include Peter J. Snyder, Bryan R. Haugen, Christine M. Chan, Arnold J. Greenspon, Matthew DeCaro, Suzanne Adams, Howard H. Weitz, David J. Whellan, Victoria Parker and Robert K. Semple and has published in prestigious journals such as Clinical Endocrinology, Thyroid and Endocrine Related Cancer.

In The Last Decade

Sarah E. Mayson

13 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. Mayson United States 10 151 77 40 32 29 14 233
Ivan Kruljac Croatia 8 55 0.4× 36 0.5× 25 0.6× 36 1.1× 11 0.4× 25 183
Philippe Chanson France 6 192 1.3× 84 1.1× 20 0.5× 72 2.3× 17 0.6× 7 272
Maria‐Cristina Burlacu Belgium 6 235 1.6× 81 1.1× 18 0.5× 21 0.7× 7 0.2× 12 317
Saba Samad Memon India 9 130 0.9× 133 1.7× 10 0.3× 44 1.4× 12 0.4× 66 270
Diana Raskauskiene United Kingdom 5 383 2.5× 190 2.5× 32 0.8× 29 0.9× 34 1.2× 7 432
Meir Berezin Israel 7 118 0.8× 63 0.8× 123 3.1× 19 0.6× 10 0.3× 8 291
E. Torres Spain 5 329 2.2× 156 2.0× 14 0.3× 43 1.3× 16 0.6× 17 409
Nicola Tufton United Kingdom 9 149 1.0× 159 2.1× 8 0.2× 26 0.8× 46 1.6× 24 245
Qinghua Guo China 11 375 2.5× 227 2.9× 22 0.6× 45 1.4× 7 0.2× 49 455
Lindsey Rigby United Kingdom 9 262 1.7× 104 1.4× 28 0.7× 18 0.6× 3 0.1× 12 324

Countries citing papers authored by Sarah E. Mayson

Since Specialization
Citations

This map shows the geographic impact of Sarah E. Mayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Mayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Mayson more than expected).

Fields of papers citing papers by Sarah E. Mayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Mayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Mayson. The network helps show where Sarah E. Mayson may publish in the future.

Co-authorship network of co-authors of Sarah E. Mayson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Mayson. A scholar is included among the top collaborators of Sarah E. Mayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Mayson. Sarah E. Mayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Randle, Reese W., et al.. (2025). Assessing ChatGPT's Capability in Addressing Thyroid Cancer Patient Queries: A Comprehensive Mixed-Methods Evaluation. Journal of the Endocrine Society. 9(2). bvaf003–bvaf003. 2 indexed citations
2.
Bell, C. David, Samantha White, Tracy S. Tylee, et al.. (2025). Thyroid Nodule Sphericity Metrics Discriminate Benign and Malignant Follicular and Oncocytic Neoplasms. Thyroid. 35(3). 291–297.
3.
Chou, Roger, Tracy Dana, Sarah E. Mayson, et al.. (2023). Ultrasound Follow-Up of Benign Thyroid Nodules: A Scoping Review. Thyroid. 33(4). 420–427. 4 indexed citations
4.
Malek, Rana, Amal Shibli‐Rahhal, Ricardo Correa, et al.. (2022). An Assessment of Diversity, Inclusion, and Health Equity Training in Endocrinology Fellowship Programs in the United States. Endocrine Practice. 28(11). 1159–1165. 2 indexed citations
5.
Figge, James, William E. Gooding, David L. Steward, et al.. (2021). Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?. Thyroid. 31(11). 1673–1682. 20 indexed citations
6.
Mayson, Sarah E., Christine M. Chan, & Bryan R. Haugen. (2021). Tailoring the approach to radioactive iodine treatment in thyroid cancer. Endocrine Related Cancer. 28(10). T125–T140. 21 indexed citations
7.
Mayson, Sarah E. & Bryan R. Haugen. (2018). Molecular Diagnostic Evaluation of Thyroid Nodules. Endocrinology and Metabolism Clinics of North America. 48(1). 85–97. 25 indexed citations
8.
Sams, Sharon B., Kenneth Tompkins, Sarah E. Mayson, Christopher D. Raeburn, & Sanjana Mehrotra. (2017). Oncocytic variant of medullary thyroid carcinoma; a rare tumor with numerous diagnostic mimics by fine needle aspiration. Diagnostic Cytopathology. 45(12). 1148–1152. 9 indexed citations
9.
Mayson, Sarah E., Julia Kharlip, John Y. Lee, et al.. (2016). Prevalence of clinically silent corticotroph macroadenomas. Clinical Endocrinology. 85(6). 874–880. 16 indexed citations
10.
Mayson, Sarah E. & Peter J. Snyder. (2014). Silent Pituitary Adenomas. Endocrinology and Metabolism Clinics of North America. 44(1). 79–87. 18 indexed citations
11.
Mayson, Sarah E. & Peter J. Snyder. (2014). Silent (clinically nonfunctioning) pituitary adenomas. Journal of Neuro-Oncology. 117(3). 429–436. 36 indexed citations
12.
Mayson, Sarah E., Don C. Yoo, & Geetha Gopalakrishnan. (2014). The Evolving Use of Radioiodine Therapy in Differentiated Thyroid Cancer. Oncology. 88(4). 247–256. 10 indexed citations
13.
Mayson, Sarah E., Victoria Parker, Mark H. Schutta, Robert K. Semple, & Michael R. Rickels. (2012). Severe Insulin Resistance and Hypertriglyceridemia After Childhood Total Body Irradiation. Endocrine Practice. 19(1). 51–58. 27 indexed citations
14.
Mayson, Sarah E., Arnold J. Greenspon, Suzanne Adams, et al.. (2007). The Changing Face of Postoperative Atrial Fibrillation Prevention. Cardiology in Review. 15(5). 231–241. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026